Correcting & Replacing -- Celularity Receives Preliminary Assessment of Product Classification and Jurisdiction for Its Investigational Celularity Tendon Wrap (CTW) to be Regulated as a Device Within U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH)
In: Plus Company Updates, 2023-02-06
Zeitungsartikel
Zugriff:
FLORHAM PARK: Celularity, Inc. has issued the following press release: Celularity Inc. (Nasdaq: CELU) ('Celularity' or the 'Company'), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced [...]
Titel: |
Correcting & Replacing -- Celularity Receives Preliminary Assessment of Product Classification and Jurisdiction for Its Investigational Celularity Tendon Wrap (CTW) to be Regulated as a Device Within U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH)
|
---|---|
Zeitschrift: | Plus Company Updates, 2023-02-06 |
Veröffentlichung: | 2023 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|